Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-29
1999-08-17
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546168, 546169, A61K 3147, C07D21514
Patent
active
059394358
ABSTRACT:
This invention relates to the use of 2-substituted-1-acyl-1,2-dihydroquinoline derivatives to increase high density lipoprotein cholesterol (HDL-C) concentration and as therapeutic compositions for treating atherosclerotic conditions such as dyslipoproteinamias and coronary heart disease.
REFERENCES:
Walters, LR et al. J. Chem. Eng. Data 16(1), 115-17, 1971.
Popp and Soto, J. Chem. Soc. 1963, 1760-1763.
Popp, "Reissert Compounds and Related N-Acyldihydroquinolines," Quinolines, Part II, (1982), John Wilen & Sons, Ltd., pp. 353-375.
Cobb and McEwen, J. Amer. Chem. Soc., 77, 5042-5048 (1955).
Walters et al., J. Het. Chem. 5, 577-578, 1968.
Babiak John
Elokdah Hassan Mahmoud
Miller Christopher Paul
Sulkowski Theodore Sylvester
American Home Products Corporation
Huang Evelyn Mei
Nagy Michael R.
LandOfFree
2-substituted-1-acyl-1,2-dihydroquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted-1-acyl-1,2-dihydroquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted-1-acyl-1,2-dihydroquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-315051